EUCTR2004-002950-67-IT进行中（未招募）不适用
Phase III, multicenter, international, randomized, partial double-blind, placebo-controlled study to evaluate the efficacy and safety of alfimeprase in subjects with acute peripheral arterial occlusion (NAPA-2)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- VELO
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of oral minoxidil in women with hormone-imbalanced hair lossFemale androgenetic alopeciaMedDRA version: 21.1Level: PTClassification code: 10068168Term: Androgenetic alopecia Class: 100000004858CTIS2023-503383-17-01Industrial Farmaceutica Cantabria S.A.440
进行中（未招募）
1 期
Controlled trial to evaluatethe efficacy and safety of glepaglutide in patients with short bowel syndromeShort bowel syndromeEUCTR2017-004394-14-PLZealand Pharma A/S108
进行中（未招募）
1 期
Controlled trial to evaluatethe efficacy and safety of glepaglutide in patients with short bowel syndromeShort bowel syndromeMedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-004394-14-GBZealand Pharma A/S129
进行中（未招募）
1 期
Controlled trial to evaluatethe efficacy and safety of glepaglutide in patients with short bowel syndromeShort bowel syndromeEUCTR2017-004394-14-ITZealand Pharma A/S129
进行中（未招募）
1 期
Controlled trial to evaluatethe efficacy and safety of glepaglutide in patients with short bowel syndromeShort bowel syndromeMedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-004394-14-DKZealand Pharma A/S108